Precision psychiatry, also termed personalized psychiatry or precision medicine in psychiatry, epitomizes a contemporary approach to psychiatric treatment, tailoring interventions to individual patients based on their unique characteristics, including genetic makeup, neurobiological markers, and environmental influences. Departing from the one-size-fits-all approach of traditional psychiatric treatments, precision psychiatry harnesses advancements in genetics, neuroimaging, and data analytics to identify biomarkers associated with psychiatric disorders and treatment response. Genetic variations influencing medication response or adverse effects can inform clinicians in optimizing medication selection and dosages, maximizing efficacy, and minimizing side effects for each patient. Neuroimaging techniques such as fMRI and EEG offer valuable insights into brain function and connectivity, aiding in identifying neural patterns linked to specific psychiatric symptoms or treatment outcomes. Moreover, precision psychiatry emphasizes considering environmental factors like stress, trauma, and lifestyle habits in understanding psychiatric disorders and tailoring treatment plans holistically. By adopting this comprehensive approach, clinicians can address underlying contributors to mental illness and customize interventions accordingly. In essence, precision psychiatry signifies a paradigm shift in psychiatric practice, toward personalized and efficacious treatments for individuals with mental health conditions. By leveraging genetics, neurobiology, and environmental factors, clinicians can deliver targeted interventions that enhance outcomes and overall well-being for patients.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States